119 related articles for article (PubMed ID: 35315165)
21. Colorectal cancer screening: 20 years of development and recent progress.
Zavoral M; Suchanek S; Majek O; Fric P; Minarikova P; Minarik M; Seifert B; Dusek L
World J Gastroenterol; 2014 Apr; 20(14):3825-34. PubMed ID: 24744575
[TBL] [Abstract][Full Text] [Related]
22. Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approach.
Deibel A; Deng L; Cheng CY; Schlander M; Ran T; Lang B; Krupka N; Beerenwinkel N; Rogler G; Wiest R; Sonnenberg A; Poleszczuk J; Misselwitz B
Gastrointest Endosc; 2021 Aug; 94(2):379-390.e7. PubMed ID: 33600806
[TBL] [Abstract][Full Text] [Related]
23. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
[TBL] [Abstract][Full Text] [Related]
24. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of a short message service intervention to motivate people with positive results in preliminary colorectal cancer screening to undergo colonoscopy: A randomized controlled trial.
Wu Y; Liang Y; Zhou Q; Liu H; Lin G; Cai W; Li Y; Gu J
Cancer; 2019 Jul; 125(13):2252-2261. PubMed ID: 30825395
[TBL] [Abstract][Full Text] [Related]
26. Do socioeconomic factors play a role in nonadherence to follow-up colonoscopy after a positive faecal immunochemical test in the Flemish colorectal cancer screening programme?
Hoeck S; van de Veerdonk W; De Brabander I
Eur J Cancer Prev; 2020 Mar; 29(2):119-126. PubMed ID: 31724969
[TBL] [Abstract][Full Text] [Related]
27. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
[TBL] [Abstract][Full Text] [Related]
28. A Centralized Program with Stepped Support Increases Adherence to Colorectal Cancer Screening Over 9 Years: a Randomized Trial.
Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Meenan RT; Vernon SW
J Gen Intern Med; 2022 Apr; 37(5):1073-1080. PubMed ID: 34047921
[TBL] [Abstract][Full Text] [Related]
29. Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review.
Lieberman D; Ladabaum U; Cruz-Correa M; Ginsburg C; Inadomi JM; Kim LS; Giardiello FM; Wender RC
JAMA; 2016 Nov; 316(20):2135-2145. PubMed ID: 27893135
[TBL] [Abstract][Full Text] [Related]
30. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
31. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies.
Brenner H; Stock C; Hoffmeister M
BMJ; 2014 Apr; 348():g2467. PubMed ID: 24922745
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area.
Cariou M; El Fettouhi A; Kermarrec T; Bommelaere F; Foll Y; Nousbaum JB; Robaszkiewicz M; Quénéhervé L
Cancer Epidemiol; 2020 Dec; 69():101839. PubMed ID: 33096500
[TBL] [Abstract][Full Text] [Related]
33. Variation in changes in the incidence of colorectal cancer by age and association with screening uptake: an observational study.
Clark GR; Anderson AS; Godfrey TG; Strachan JA; Fraser CG; Steele RJ
BMJ Open; 2020 Sep; 10(9):e037925. PubMed ID: 32963068
[TBL] [Abstract][Full Text] [Related]
34. Follow-up of patients undergoing both semiquantitated immunochemical fecal occult blood and colonoscopy examinations.
Rozen P; Liphshitz I; Barchana M
Eur J Cancer Prev; 2012 May; 21(3):247-53. PubMed ID: 21955798
[TBL] [Abstract][Full Text] [Related]
35. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
36. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
37. Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.
Geraghty J; Butler P; Seaman H; Snowball J; Sarkar S; Blanks R; Halloran S; Bodger K; Rees CJ
Br J Cancer; 2014 Nov; 111(11):2156-62. PubMed ID: 25225905
[TBL] [Abstract][Full Text] [Related]
38. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
